CEL 9.27 Cellcom Israel $CEL Hit a 52 week low of 9.26

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 11:04 AM

CEL 9.27 Cellcom Israel $CEL Hit a 52 week low of 9.26 Closing the day 10:40 at 9.27 -0.19 -2.01% With a day low of 9.26 and a total volume of 12,158.

CEL Recent Posts: http://investorshangout.com/Cellcom-Israel-CEL-50483/

CEL Cellcom Israel Recent Headline News

25.8% Return Seen to Date on SmarTrend Cellcom Israel Call (CEL)
Comtex SmarTrend(R) - 41 mins ago
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 25.78% as of today's recent price of $9.33.
CEL: 9.27 (-0.19)

Cellcom Israel ltd. Announces Annual General Meeting of Shareholders
PR Newswire - Thu Nov 13, 5:21AM CST
Cellcom Israel Ltd. (NYSE: CEL) announced today that an Annual General Meeting of Shareholders (the "Meeting"

of Cellcom Israel Ltd. (the "Company"

will be held on Tuesday, December 23, 2014, at 4:00 p.m. (Israel time), at the offices of the Company, 10 Hagavish Street, Netanya, Israel. The record date for the Meeting is Monday, November 24, 2014.
CEL: 9.27 (-0.19)

Cellcom Israel's (CEL) CEO Nir Sztern on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 9:36AM CST

CEL: 9.27 (-0.19)

Cellcom Israel EPS of $0.28
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 6:04AM CST

CEL: 9.27 (-0.19)

Cellcom posts 3Q profit
Automated Insights - Wed Nov 12, 4:04AM CST
NETANYA, Israel (AP) _ Cellcom Israel Ltd. (CEL) on Wednesday reported profit of $29 million in its third quarter.
CEL: 9.27 (-0.19)

Cellcom Israel Announces Third Quarter 2014 Results
PR Newswire - Wed Nov 12, 1:06AM CST
THIRD QUARTER 2014 HIGHLIGHTS (compared to third quarter of 2013):
CEL: 9.27 (-0.19)

Cellcom Israel Has Returned 21.5% Since SmarTrend Recommendation (CEL)
Comtex SmarTrend(R) - Wed Nov 05, 4:59PM CST
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 21.48% as of today's recent price of $9.87.
CEL: 9.27 (-0.19)

Cellcom Israel Shares Down 16.1% Since SmarTrend's Sell Call (CEL)
Comtex SmarTrend(R) - Wed Oct 29, 11:04AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 6 months, Cellcom Israel has returned 16.15% as of today's recent price of $10.54.
CEL: 9.27 (-0.19)

Cellcom Israel Schedules Third Quarter 2014 Results Release For November 12, 2014
PR Newswire - Sun Oct 26, 7:56AM CDT
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"

, announced today that it will be releasing its financial results for the third quarter ended September 30, 2014 on Wednesday, November 12, 2014, before the US markets open.
CEL: 9.27 (-0.19)

Downtrend Call Working As Cellcom Israel Stock Falls 14.6% (CEL)
Comtex SmarTrend(R) - Wed Oct 15, 9:27AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 5 months, Cellcom Israel has returned 14.56% as of today's recent price of $10.74.
CEL: 9.27 (-0.19)

Nokia Enhances Offerings, Cuts Vital Deals: Should You Buy? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 1:00PM CDT
On Oct 8, 2014, Zacks Investment Research upgraded Finnish telecommunication company Nokia Corporation (NOK) by a notch to a Zacks Rank #2 (Buy).
CEL: 9.27 (-0.19), BBRY: 11.53 (+0.26), ARUN: 21.89 (+0.25), NOK: 8.25 (+0.20)

Is Cellcom Israel (CEL) Stock A Great Combo of Value and Growth? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 7:46AM CDT
Cellcom Israel may be an interesting play thanks to its forward PE of 10.5, its P/S ratio of 0.82, and its decent dividend yield of 2.15%
CEL: 9.27 (-0.19)

UPRO, NJ, CEL, SYT, HUN, CALD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 03, 4:23AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares UltraPro S&P 500 (NYSE:UPRO), Nidec Corp (NYSE:NJ), Columbus Energy Ltd (NYSE:CEL), Syngenta AG (NYSE:SYT), Huntsman Corp (NYSE:HUN), Callidus Software Inc (NASDAQ:CALD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CEL: 9.27 (-0.19), UPRO: 130.00 (+1.32), SYT: 65.44 (+1.73), NJ: 15.94 (+0.09), CALD: 15.64 (unch), HUN: 24.99 (+0.10)

Cellcom Israel Down 10.3% Since SmarTrend Downtrend Call (CEL)
Comtex SmarTrend(R) - Fri Sep 26, 9:58AM CDT
SmarTrend identified a Downtrend for Cellcom Israel (NYSE:CEL) on May 6th, 2014 at $12.57. In approximately 5 months, Cellcom Israel has returned 10.34% as of today's recent price of $11.27.
CEL: 9.27 (-0.19)

Cellcom Israel reports dismissal of purported class action and filing of a purported class action
M2 - Wed Sep 24, 6:51AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Tuesday the dismissal with prejudice by the Israeli Supreme Court an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against Netvision Ltd, the company's wholly owned subsidiary, and other defendants, regarding on-line auctions of goods.
CEL: 9.27 (-0.19)

Cellcom Israel claims win in court case
M2 - Wed Sep 24, 4:58AM CDT
Israel-based Cellcom Israel Ltd (NYSE: CEL) (TASE: CEL) said that the Israeli Supreme Court dismissed with prejudice an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against the company's Netvision Ltd subsidiary and other defendants regarding on-line auctions of goods.
CEL: 9.27 (-0.19)

Cellcom Israel Ltd. Announces Dismissal of Purported Class Action and Filing of a Purported Class Action
PR Newswire - Tue Sep 23, 6:39AM CDT
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"

announced today that the Israeli Supreme Court dismissed with prejudice an appeal filed in 2011 against the dismissal with prejudice of a purported class action filed against Netvision Ltd., the Company's wholly owned subsidiary, and other defendants, regarding on-line auctions of goods. The total amounts claimed from the defendents, had the lawsuit been certified as class action wasn't quantified by the plaintiffs. In addition, a purported class action was filed against 013 Netvision Ltd., or Netvision, the Company's wholly owned subsidiary, in relation to sums Netvision allegedly wrongfully charged its subscribers, relating to their payment method. The total amounts claimed from Netvision, if the lawsuit is certified as class action is estimated by the plaintiff to be over NIS 50 million (and under certain mistaken assumptions detailed elsewhere in the lawsuit- over NIS 1 billion). At this early stage the Company cannot assess the lawsuit's chances of success.
CEL: 9.27 (-0.19)

Cellcom Israel announces board changes under Israeli law
M2 - Tue Sep 23, 6:34AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Monday the resignation of Rafi Bisker, Haim Gavrieli and Edith Lusky resigned from their office as members of the company's board of directors, effective 21 September 2014.
CEL: 9.27 (-0.19)

Cellcom Israel enters into agreements with Golan and Pelephone for networks
M2 - Tue Sep 23, 6:29AM CDT
Israeli cellular provider Cellcom Israel Ltd (NYSE:CEL) (TASE:CEL.TA) announced on Monday, that following the network sharing agreements, and the Israeli Ministry of Communications requirements regarding network sharing, it has now signed more agreements.
CEL: 9.27 (-0.19)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...